| 臺大學術典藏 |
2021-07-12T02:10:24Z |
DNA methylome and transcriptome landscapes of cancer-associated fibroblasts reveal a smoking-associated malignancy index
|
SU, SHENG-FANG; Ho, Hao; Li, Jia-Hua; Wu, Ming-Fang; Wang, Hsu-Chieh; Yeh, Hsiang-Yuan; Kuo, Shuenn-Wen; Chen, Huei-Wen; Ho, Chao-Chi; Li, Ker-Chau |
| 臺大學術典藏 |
2021-07-12T02:24:08Z |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses
|
SU, SHENG-FANG; Liu, Chia-Hsin; Cheng, Chiou-Ling; Ho, Chao-Chi; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Huei-Wen; Chang, Gee-Chen; Yu, Sung-Liang; Li, Ker-Chau |
| 臺大學術典藏 |
2021-07-12T02:44:18Z |
Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses
|
Lin P.-H; | Liang C.-Y; | Yao B.-Y; | Chen H.-W; | Pan C.-F; | Wu L.-L; | Lin Y.-H; | Hsu Y.-S; | Liu Y.-H; | Chen P.-J; | Hu C.-M.J; | HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-07-12T02:44:18Z |
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
|
Lin S.-R; | Yang T.-Y; | Peng C.-Y; | Lin Y.-Y; | Dai C.-Y; | Wang H.-Y; | Su T.-H; | Tseng T.-C; | Liu I.-J; | Cheng H.-R; | Shen Y.-C; | Wu F.-Y; | Liu C.-J; | Chen D.-S; | Chen P.-J; | HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:19Z |
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load
|
Tseng T.-C; | Liu C.-J; | Yang W.-T; | Hsu C.-Y; | Hong C.-M; | Su T.-H; | Tsai C.-H; | Chen C.-L; | HUNG-CHIH YANG; | Liu C.-H; | Chen H.-H; | Chen P.-J; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:20Z |
Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease
|
Huang S.-C; | Su H.-J; | Kao J.-H; | Tseng T.-C; | HUNG-CHIH YANG; | Su T.-H; | Chen P.-J; | Liu C.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:20Z |
Direct comparison of biopsy techniques for hepatic malignancies
|
Huang S.-C; | Liang J.-D; | Hsu S.-J; | Hong T.-C; | HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:21Z |
Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan
|
Su H.-J; | Kao J.-H; | Tseng T.-C; | HUNG-CHIH YANG; | Su T.-H; | Chen P.-J; | Liu C.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:21Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y; | Chiu Y.-C; | Chiu F.-W; | Hsu Y.-C; | Tseng T.-C; | Cheng P.-N; | Yang S.-S; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:21Z |
Relationship between serum gamma-glutamyl transferase level and colorectal adenoma
|
Hong T.-C; | HUNG-CHIH YANG; | Chen C.-L; | Kao J.-H; | Liu C.-J; | Chen M.-J; | Wang H.-Y; | Kuo Y.-C; | Yu L.-Y; | Hu K.-C. |
| 臺大學術典藏 |
2021-07-12T02:44:22Z |
Benzarone-induced liver injury: First case report in Asia
|
Tseng H.-H; | Tseng L.-W; | HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-07-12T02:44:22Z |
Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943�V2020)
|
HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:22Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
Su T.-H; | Tseng T.-C; | Liu C.-J; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:22Z |
Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study
|
Lee M.-R; | Huang H.-L; | Chen L.-C; | HUNG-CHIH YANG; | Ko J.-C; | Cheng M.-H; | Chong I.-W; | Lee L.-N; | Wang J.-Y; | Dimopoulos G. |
| 臺大學術典藏 |
2021-07-12T02:44:23Z |
Hepatitis B reactivation: diagnosis and management
|
Huang S.-C; | HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:23Z |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
Hong C.-M; | Liu C.-H; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen Y.-W; | Kao J.-H; | Liu C.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:23Z |
Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing
|
Yang Y.-C; | Chen Y.-H; | Kao J.-H; | Ching C; | Liu I.-J; | Wang C.-C; | Tsai C.-H; | Wu F.-Y; | Liu C.-J; | Chen P.-J; | Chen D.-S; | HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-07-12T02:44:24Z |
Epidemiology and management of HCV Infection
|
HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-07-12T02:44:24Z |
HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis
|
Tseng T.-C; | Liu C.-J; | Chang C.T; | Su T.-H; | Yang W.-T; | Tsai C.-H; | Chen C.-L; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:24Z |
Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy
|
Tseng T.-C; | Peng C.-Y; | Hsu Y.-C; | Su T.-H; | Wang C.-C; | Liu C.-J; | HUNG-CHIH YANG; | Yang W.-T; | Lin C.-H; | Yu M.-L; | Lai H.-C; | Tanaka Y; | Nguyen M.H; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:25Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H; | HUNG-CHIH YANG; | Hsiao C.-F; | Hsiung C.A; | Liu T.-W; | Chuang M.-H; | Wu H.-Y; | Hsu Y.-T; | Tsui C.-W; | Chen P.-J; | Cheng A.-L; | Hsu C; | Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-12T02:44:25Z |
Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis
|
Su T.-H; | Peng C.-Y; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-J; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:25Z |
High Level of Hepatitis B Core�VRelated Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load
|
Tseng T.-C; | Liu C.-J; | Hsu C.-Y; | Hong C.-M; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Huang Y.-T; | Fang-Tzu Kuo S; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:26Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Chou S.-W; | Lin C.-H; | Liu C.-H; | Liu C.-J; | Chen C.-L; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:26Z |
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
|
Su T.-H; | Liao S.-H; | Hong C.-M; | Liu C.-J; | Tseng T.-C; | Liu C.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Adhoute X; | Bourli?re M; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:27Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu C.-H; | Shih Y.-L; | Yang S.-S; | Lin C.-L; | Fang Y.-J; | Cheng P.-N; | Chen C.-Y; | Peng C.-Y; | Hsieh T.-Y; | Chiu Y.-C; | Su T.-H; | Liu C.-J; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:27Z |
A global scientific strategy to cure hepatitis B
|
Revill P.A; | Chisari F.V; | Block J.M; | Dandri M; | Gehring A.J; | Guo H; | Hu J; | Kramvis A; | Lampertico P; | Janssen H.L.A; | Levrero M; | Li W; | Liang T.J; | Lim S.-G; | Lu F; | Penicaud M.C; | Tavis J.E; | Thimme R; | Arbuthnot P; | Boonstra A; | Chang K.-M; | Chen P.-J; | Glebe D; | Guidotti L.G; | Fellay J; | Ferrari C; | Jansen L; | Lau D.T.Y; | Lok A.S; | Maini M.K; | Mason W; | Matthews G; | Paraskevis D; | Petersen J; | Rehermann B; | Shin E.-C; | Thompson A; | van B?mmel F; | Wang F.-S; | Watashi K; | HUNG-CHIH YANG; | Yuan Z; | Yuen M.-F; | Block T; | Miller V; | Protzer U; | Br?chot C; | Locarnini S; | Peters M.G; | Schinazi R.F; | Zoulim F; | Members of the ICE-HBV Working Groups, ICE-HBV Stakeholders Group Chairs, ICE-HBV Senior Advisors |
| 臺大學術典藏 |
2021-07-12T02:44:27Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Liu C.-H; | Su T.-H; | Liu C.-J; | Hong C.-M; | HUNG-CHIH YANG; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:28Z |
Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice
|
Wu L.-L; | Peng W.-H; | Wu H.-L; | Miaw S.-C; | Yeh S.-H; | HUNG-CHIH YANG; | Liao P.-H; | Lin J.-S; | Chen Y.-R; | Hong Y.-T; | Wang H.-Y; | Chen P.-J; | Chen D.-S. |
| 臺大學術典藏 |
2021-07-12T02:44:28Z |
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma
|
Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:29Z |
Profile and value of FIB-4 in patients with dual chronic hepatitis C and B
|
Liu C.-J; | Tseng T.-C; | Yang W.-T; | Su T.-H; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:29Z |
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
|
Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:29Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Liu C.-H; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:29Z |
Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus
|
HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:30Z |
Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B
|
Papatheodoridis G.V; | Manolakopoulos S; | Su T.-H; | Siakavellas S; | Liu C.-J; | Kourikou A; | HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:30Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Liu C.-H; | Huang Y.-J; | Yang S.-S; | Chang C.-H; | Yang S.-S; | Sun H.-Y; | Liu C.-J; | Liu W.-C; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Hung C.-C; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:31Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
HUNG-CHIH YANG; | Tsou H.-H; | Pei S.-N; | Chang C.-S; | Chen J.-H; | Yao M; | Lin S.-J; | Lin J; | Yuan Q; | Xia N; | Liu T.-W; | Chen P.-J; | Cheng A.-L; | Hsu C; | Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-12T02:44:31Z |
Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy
|
Su T.-H; | Liao C.-H; | Liu C.-H; | Huang K.-W; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-J; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:32Z |
Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection
|
Lin P.-H; | Wong W.-I; | Wang Y.-L; | Hsieh M.-P; | Lu C.-W; | Liang C.-Y; | Jui S.-H; | Wu F.-Y; | Chen P.-J; | HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-07-12T02:44:32Z |
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection
|
Liu C.-H; | Sun H.-Y; | Liu C.-J; | Sheng W.-H; | Hsieh S.-M; | Lo Y.-C; | Liu W.-C; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Hung C.-C; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:32Z |
Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection
|
Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:33Z |
Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy
|
Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Liou J.-M; | Liu C.-H; | Chen C.-L; | Chen P.-J; | Chen D.-S; | Liu C.-J; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:33Z |
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan
|
Liu C.-H; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:33Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu C.-H; | Chen Y.-S; | Wang S.-S; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:34Z |
The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA
|
HUNG-CHIH YANG; | Chen P.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:34Z |
A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patients
|
Liu C.-H; | Liu C.-J; | Hong C.-M; | Su T.-H; | HUNG-CHIH YANG; | Chen K.-M; | Huang Y.-P; | Yeh Y.-M; | Tien H.-L; | Liu Y.-C; | Kao J.-H; | Chen D.-S; | Chen P.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:34Z |
Viral factors affecting disease progression
|
HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-07-12T02:44:35Z |
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
|
Su T.-H; | Shiau C.-W; | Jao P; | Yang N.-J; | Tai W.-T; | Liu C.-J; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-H; | Huang K.-W; | Hu T.-C; | Huang Y.-J; | Wu Y.-M; | Chen L.-J; | Chen P.-J; | Chen D.-S; | Chen K.-F; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:35Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee M.-H; | Huang C.-F; | Lai H.-C; | Lin C.-Y; | Dai C.-Y; | Liu C.-J; | Wang J.-H; | Huang J.-F; | Su W.-P; | HUNG-CHIH YANG; | Kee K.-M; | Yeh M.-L; | Chuang P.-H; | Hsu S.-J; | Huang C.-I; | Kao J.-T; | Chen C.-C; | Chen S.-H; | Jeng W.-J; | Yang H.-I; | Yuan Y; | Lu S.-N; | Sheen I.-S; | Liu C.-H; | Peng C.-Y; | Kao J.-H; | Yu M.-L; | Chuang W.-L; | Chen C.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:36Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
